Cencora, Inc.COR

Healthcare
Neutral

ASignal's systematic analysis rates COR as Neutral. Cencora, Inc. has a market cap of $60.23B, a P/E of 23.31, a 0.8% net margin, and 3.8% year-over-year revenue growth.

Reflects the latest available analysis · analyzed Jul 9, 2026

The case on COR

Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.

Bull case
  • Strong ROE of 107.13%
  • Forward P/E of 15.63x below current P/E of 23.31x
  • Low PEG ratio of 0.63x indicating growth at reasonable price
  • EV/Revenue of 0.22x suggests undervaluation relative to sales
  • Positive MACD histogram indicating strengthening momentum
  • Price above SMA20 and SMA50 showing intermediate-term uptrend
VS
Bear case
  • RSI at 73.79 indicating overbought condition
  • Price trading above upper Bollinger Band suggesting potential pullback
  • Negative free cash flow of -$318.25M
  • High debt-to-equity ratio of 4.21x
  • Low gross margin of 3.80% indicating weak pricing power
  • Current ratio of 0.95x and quick ratio of 0.48x signaling liquidity concerns

Key facts

Sector
Healthcare
Market cap
$60.23B
P/E ratio
23.31
Gross margin
3.8%
Net margin
0.8%
Rev growth YoY
3.8%
Price (Jul 9, 2026)
$309.57

Peers

Clustered with COR by analysis-profile similarity.

Subscriber-only

See the full verdict on COR

ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.

How ASignal analyzes COR

Most investors never get a second opinion, let alone several. ASignal runs COR past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.

The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.

Cencora, Inc. (COR) Stock Analysis - ASignal rates it Neutral